Research, Select, & Monitor Friday, February 22, 2019 9:29:33 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Tecogen Inc.$3.80($.10)(2.56%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Tecogen Inc. vs Biotechnology

Tecogen Inc. designs, manufactures, sells, and services systems that produce electricity, hot water, and air conditioning for commercial installations and buildings and industrial processes. The Company's ultra-efficient products include cogeneration modules, which provide electricity and heat, and chillers, which provide air-conditioning and optional free hot water. Its products supply electrical power or mechanical power for cooling, as well as free engine heat that gets recovered and purposefully used at customer facilities. Tecogen Inc. is based in United States.

An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: N/A $90,525.4 Mil
  Market Cap: $96.8 Mil $476,209.3 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: N/A 49.0%
  Estimated Revenue: N/A 14.5%
  Historic Earnings: N/A 10.2%
  Estimated Earnings: N/A 21.7%
  Stock Price (1 Year): 69.6% 21.0%
  Cash per Share: N/A 52.9%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 34.5 40.1
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A 5.9
  Dividend Yield: N/A N/A
  Market Cap: $96.8 Mil $10,582.4 Mil
  Net Margin: N/A (498.4%)
  Gross Margin: N/A 80.7%
  Return on Equity: N/A .1
  Return on Assets: N/A (.1)
  Balance Sheet
  Current Ratio: N/A 3.3
  Quick Ratio: N/A 3.0
  Cash Ratio: N/A 2.2
  Debt-to-Equity: N/A 1.1
  Interest Coverage: N/A (.5)
  Relative-Strength Index: N/A 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $187.50 $118,204.3 Mil
  Gilead Sciences, Inc.  (GILD) $65.74 $84,796.8 Mil
  Biogen Inc.  (BIIB) $325.33 $64,709.3 Mil
  Celgene Corp.  (CELG) $89.14 $62,146.3 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $422.52 $45,633.8 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.